Predominantly third-line pancreatic cancer patients demonstrated durable survival despite advanced disease; patient who received Namodenoson as ...
Detailed price information for Can-Fite Biopharma Ltd ADR (CANF-A) from The Globe and Mail including charting and trades.
Ramat Gan, Israel, April 14, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small-molecule drugs for ...
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a clinical-stage biotechnology company developing a pipeline of proprietary small molecule drugs targeting oncological and inflammatory ...
Can-Fite BioPharma Ltd. CANF, a clinical-stage biotech, saw its shares jump on Friday after the company secured a Japanese ...
London, UK, Jan. 02, 2024 (GLOBE NEWSWIRE) -- The FITE team proudly announces the launch of their groundbreaking platform in the Centralized Finance (CeFi) arena, named FITE—an acronym for "First In ...
East Texas native C.J. Fite, a standout defensive lineman for Arizona State, shares how his faith influenced his decision to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results